研究刻画美国临床医生对AI平台OpenEvidence的使用情况
Study characterizes clinicians' use of the AI platform OpenEvidence
发表于JAMA的研究分析了2024年1月至2026年6月美国临床医生对AI平台OpenEvidence的使用情况,近95.2万名医生提交约2.71亿次查询。该平台在护士 practitioners、医师助理、早期职业医生、住院医及肿瘤/血液科、内科和Family medicine医生中尤为流行。大多数查询涉及治疗和管理决策,而非诊断,且医生常寻求本专业之外的信息。
Artificial intelligence–enabled tools allow clinicians to ask questions like, "How should I explain cholesterol levels to a patient?" or "What were the outcomes of the ATLANTIS trial?" and receive synthesized responses in seconds. However, data on which clinicians use these tools, how often they use them and for what purposes have remained limited.
A new study led by Vishal Patel, M.D., M.P.H., and overseen by Anupam Jena, M.D., Ph.D., both of Mass General Brigham and Harvard Medical School, helps close these knowledge gaps. The researchers analyzed clinicians' use of OpenEvidence, the most widely used AI-powered clinical platform in the United States.
The study is published in the journal JAMA.
Between January 2024 and June 2026, active users, query volume and user retention increased dramatically. Overall, nearly 952,000 clinicians submitted approximately 271 million queries through the platform.
OpenEvidence was used widely across the clinical workforce but was especially popular among nurse practitioners, physician assistants, early-career physicians, residents and fellows. Use was also higher among physicians in oncology/hematology, internal medicine and family medicine, and lower among those in ophthalmology, radiology, orthopedics and anesthesiology.
Researchers also analyzed patterns in query purpose and medical topic area. Most queries related to treatment and management decisions rather than diagnosis, and clinicians frequently sought information outside their primary specialty.
By providing one of the first large-scale views of how clinicians use a clinical AI platform in practice, the study may help inform future efforts to evaluate and integrate AI tools in clinical medicine.
Publication details
Vishal R. Patel et al., Clinician Use of an Artificial Intelligence–Enabled Clinical Information Platform, JAMA (2026). DOI: 10.1001/jama.2026.21868
Journal information: Journal of the American Medical Association
Clinical categories
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Alexander Pol
PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →
Citation: Study characterizes clinicians' use of the AI platform OpenEvidence (2026, October 16) retrieved 16 October 2026 from https://medicalxpress.com/news/2026-10-characterizes-clinicians-ai-platform-openevidence.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com